1. A compound of the general Formula (I):
wherein
R1, R2, R3 and R4, identical or different, represent a hydrogen atom, a hydroxyl group, a linear or branched (C1-C6) alkyl group, a linear or branched (C1-C6) alkoxy group, a linear or branched (C1-C6) carboxylate group,
R5 represents a hydrogen atom or a linear or branched (C1-C6) alkyl group,
m is an integer between 1 and 2, and
n is an integer between 8 and 20.
2. The compound according to claim 1, wherein n is an integer between 8 and 16.
3. The compound according to claim 2, wherein n is an integer equal to 8, 10, 12, 13, 14 or 16.
4. The compound according to claim 1, wherein the compound is a compound selected from TFA12, TFA14, TFA15, TFA16 and TFA18.
5. The compound according to claim 1, wherein R5 represents a hydrogen atom or a methyl group.
6. The compound according to claim 1, wherein the carbon atom bearing the substituent R5 has the R or S configuration or is a mixture.
7. The compound of Formula (I) according to claim 1, wherein at least one, of the substituents R1, R2, R3 and R4 on the aromatic ring, represents a hydroxyl, alkoxy or carboxylate group.
8. The compound of Formula (I) according to claim 1, wherein the linear or branched C1-C6 alkyl group is the methyl, ethyl, isopropyl or tert-butyl radical.
9. The compound of Formula (I) according to claim 1, wherein the linear or branched (C1-C6) alkoxy group is the methoxy, ethoxy, isopropoxy or tertiary-butoxy group.
10. A pharmaceutical composition comprising a compound of the general Formula (I):
wherein
R1, R2, R3 and R4, identical or different, represent a hydrogen atom, a hydroxyl group, a linear or branched (C1-C6) alkyl group, a linear or branched (C1-C6) alkoxy group, a linear or branched (C1-C6) carboxylate group,
R5 represents a hydrogen atom or a linear or branched (C1-C6) alkyl group,
m is an integer between 1 and 2, and
n is an integer between 8 and 20, with a pharmaceutically acceptable carrier.
11. A pharmaceutical composition comprising at least one compound having the following general Formula (I) as the active principle:
wherein
R1, R2, R3 and R4, identical or different, represent a hydrogen atom, a hydroxyl group, a linear or branched (C1-C6) alkyl group, a linear or branched (C1-C6) alkoxy group, a linear or branched (C1-C6) carboxylate group,
R5 represents a hydrogen atom or a linear or branched (C1-C6) alkyl group,
m is an integer between 1 and 2, and
n is an integer between 8 and 20, for
stimulating the modulation of the specification of the neural stem cells andor the differentiation of cells that are precursors of oligodendrocytes in oligodendroglial cells andor repressing the activation of microglial cells andor the activation of astrocytes andor reactive gliosis, in association with a pharmaceutically acceptable carrier.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. An easily-peelable film, which comprises a sealing layer having the thickness of 1 to 20 m comprising a polyester resin, and a layer adjacent to the sealing layer and comprising at least one kind of ethylene copolymer selected from the group consisting of an ethyleneunsaturated carboxylic ester copolymer and an ethylenevinyl acetate copolymer.
2. The easily-peelable film according to claim 1, wherein the ethylene content in the ethylene copolymer is 50 to 85% by weight.
3. The easily-peelable film according to claim 1, wherein the layer adjacent to the sealing layer is a layer comprising an ethyleneunsaturated carboxylic ester copolymer.
4. The easily-peelable film according to claim 3, wherein the ethyleneunsaturated carboxylic ester copolymer is an ethylene-methyl acrylate copolymer or an ethylene-methyl methacrylate copolymer.
5. The easily-peelable film according to claim 1, wherein the thickness of the sealing layer is 3 to 10 m.
6. A lid member comprising the easily-peelable film as defined in claim 1.
7. A packaging body comprising lid member as defined in claim 6.